A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
REDUCTION OF DOXORUBYCIN TOXICITY BY CERULOPLASMIN ÇÌÅÍØÅÍÍß ÒÎÊÑÈ×Íί IJ¯ ÄÎÊÑÎÐÓÁ²ÖÈÍÓ ÇÀ ÄÎÏÎÌÎÃÎÞ ÖÅÐÓËÎÏËÀÇ̲ÍÓ
2000
Experimental Oncology
unpublished
Preserved Fulltext
²íñòèòóò åêñïåðèìåíòàëüíî¿ ïàòîëî㳿, îíêîëî㳿 ³ ðàä³îá³îëî㳿 ³ì. Ð.ª. Êàâåöüêîãî ÍÀÍ Óêðà¿íè, Êè¿â, Óêðà¿íà Ceruloplasmin as a natural antioxidant prevents intensification of lipid peroxidation caused by tumor growth and doxorubicin intoxication. Ceruloplasmin has not been shown to decrease anticancer activity of doxorubicin. Liquid form of ceruloplasmin judging by its activity has been found to be as well effective as lyophilized form of the drug.
fatcat:oqdeuirpfja5bfqbuk7t65vuey